InscoBi

InscoBi is a South Korean biotechnology and medical device company that operates across diverse sectors including healthcare, smart grid technology, and telecommunications. In the life sciences space, the company focuses on the development of innovative treatments for hair loss and erectile dysfunction, as well as metabolic diseases like diabetes and obesity. Through its subsidiaries and partnerships, InscoBi is advancing a pipeline of peptide-based therapeutics and medical devices. The company is notably involved in the development of 'Balman', a functional hair care brand, and is pursuing clinical trials for its pharmaceutical candidates. InscoBi is publicly traded on the Korea Stock Exchange (KRX).